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CLINICAL VIGNETTETranscatheter Aortic Valve-in-Valve
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Aorto-Right Ventricular Fistula
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MaWe describe the case of a degenerative, sutureless bioprosthetic valve (BPV) with deformation and stent infolding in a
patient with elevated surgical risk. Following discussion among the heart team, balloon valve fracture was performed to
facilitate deployment of an aortic valve-in-valve transcatheter heart valve. Post-procedural imaging demonstrated BPV
frame protrusion and contained annular rupture, which required operative intervention. (Level of Difficulty: Interme-
diate.) (J Am Coll Cardiol Case Rep 2020;2:309–11) © 2020 The Authors. Published by Elsevier on behalf of the American
College of Cardiology Foundation. This is an open access article under the CC BY license (http://creativecommons.org/
licenses/by/4.0/).A n 81-year-old female presented with New York Heart Association functional class III symptoms ofbreathlessness. She had undergone implantation of a 19-mm Perceval (LivaNova, Markham, Ontario,Canada) sutureless bioprosthetic valve (BPV) 2 years previously for high-risk severe native aortic ste-
nosis. Computed tomography (CT) demonstrated stent infolding and collapse (Figure 1A). Transthoracic echo-
cardiography confirmed degenerative BPV failure with severe valvular and paravalvular aortic regurgitation
(1). Coronary angiography demonstrated unobstructed coronary arteries with fluoroscopic confirmation of
valve design (Figure 1B). Following review of the imaging and clinical history, the heart team consensus was
to proceed with aortic valve-in-valve transcatheter heart valve (THV) implantation using a 23-mm Sapien S3
(Edwards Lifesciences, Irvine, California) and previous fracture of the distorted bioprosthetic valve frame.
The valve-in-valve procedure was performed through the transfemoral route under transesophageal echocar-
diographic (TEE) guidance. BPV crossing was performed using a pigtail catheter exchanged for a standard
curved Safari wire (Boston Scientific, Marlborough, Massachusetts) for support. Bioprosthetic valve fracture
was performed successfully using a 20-mm Atlas Gold (CR Bard, Murray Hill, New Jersey) balloon dilation cath-
eter (Video 1). A 23-mm Sapien 3 (Edwards Lifesciences) THV was then deployed at nominal volume under
rapid pacing at 210 beats/min on the Safari wire (Boston Scientific) (Figure 1C, Video 2). After THV implantation
imaging demonstrated no paravalvular leakage, however, there was suggestion of a contained rupture andN 2666-0849 https://doi.org/10.1016/j.jaccas.2019.11.086
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310fistulous connection between the left ventricular outflow tract and right ventricle on both TEE
(Figure 1D, Video 3) and left ventriculography (Video 4). Hemodynamic stability was maintained
throughout the procedure, and the contained rupture was concluded to be benign. After THV implan-
tation, contrast-enhanced CT (2-dimensional [2D] and 3D reconstruction) confirmed a clear contrast
leak at the level of the aortic neosinuses and the waist of the THV into the right ventricular outflow
tract through the valve frame (Figures 1E and 1F). Within 12 h, the patient’s hemodynamic status
acutely deteriorated and required urgent resternotomy as an inpatient (Figure 1G). The THV and orig-
inal Perceval sutureless valves were retrieved and the aortic valve and root replacement procedures
were redone (Figure 1H). The Central Illustration depicts the transcatheter heart valve inside the
Perceval bioprosthesis and the anatomical position of the fistula. Perceval valve degeneration treated
with valve-in-valve THV implantation has been previously reported (1). However, this is the first
report of fistula formation following valve-in-valve transcatheter aortic valve replacement in this
valve, despite appropriate sizing. There are limited data, but the ENCORE (European ContainedRupture Registry) would support a benign course of initially asymptomatic contained ruptures. This contained
rupture was hypothesized to have occurred following THV expansion as a result of BPV frame protrusion and
was associated with late hemodynamic collapse. Further experience is required particularly when performing
valve-in-valve for structural degeneration of sutureless valves, despite good outcomes in published registry
data (2,3).
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Westminster Bridge Road, London SE1 7EH, United Kingdom. E-mail: tiffanypatterson05@gmail.com.tent Infolding, Distortion, and Collapse of Perceval Sutureless Valve
ent infolding, distortion, and collapse of Perceval Sutureless valve. (B) Left anterior oblique view of a Perceval Sutureless valve during
Orthogonal view of a successful Sapien S3 valve-in-valve implant. (D) Mid-esophageal long-axis view on TEE demonstrates a fistulous
color Doppler flow) between the right coronary cusp and right ventricle. Axial (E) CT imaging of well-deployed valve-in-valve with
w) confirmed by contrast leak (F). This is also demonstrated by 3-dimensional CT reconstruction (white arrow). (G) Resternotomy for
and Perceval Sutureless (right) valves retrieved perioperatively. AVR ¼ aortic valve replacement; CT ¼ computed tomography;
diography.
CENTRAL ILLUSTRATION Image of the Patient’s Cardiac Anatomy
Patterson, T. et al. J Am Coll Cardiol Img. 2020;2(2):309–11.
This demonstrates the heart in cross section, with the transcatheter heart valve (TAVR) implanted with the Perceval sutureless valve. The
aorto-right ventricular fistula has created a shunt from the left ventricle (LV) to the right ventricle (RV). LA ¼ left atrium; MV ¼mitral valve;
RA ¼ right atrium.
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